Why is it crucial to avoid mixing Advil and MAOIs?
Advil, which contains ibuprofen, is a nonsteroidal anti-inflammatory drug (NSAID), while MAOIs (monoamine oxidase inhibitors) are a class of antidepressants. The risks of mixing these two medications are significant and can lead to severe health complications [1].
What is the potential for serotonin syndrome?
When mixed with MAOIs, ibuprofen can increase the risk of serotonin syndrome, a potentially life-threatening condition caused by excessive levels of serotonin in the body. Serotonin syndrome can lead to symptoms such as dizziness, weakness, tremors, confusion, agitation, and even heart problems [2].
How does this interaction occur?
Ibuprofen inhibits the breakdown of serotonin in the body, which can lead to an accumulation of the neurotransmitter. When combined with MAOIs, which also increase serotonin levels, the combination can lead to a massive increase in serotonin levels, triggering serotonin syndrome [3].
Is it a common interaction, and who is most at risk?
While it is not a well-known interaction, the combination of ibuprofen and MAOIs can occur accidentally in patients who take both medications. Older adults, those with kidney or liver disease, and individuals taking other medications that interact with MAOIs or NSAIDs are at increased risk [4].
What can happen if left unchecked?
Untreated serotonin syndrome can lead to serious complications, including seizures, coma, and death. Timely medical attention is essential if symptoms of serotonin syndrome occur [5].
Can this interaction be mitigated?
Patients should inform their healthcare providers about all medications, including over-the-counter pain relievers, to avoid this potential interaction. If a patient must take both medications, their healthcare provider should closely monitor them for signs of serotonin syndrome and adjust their treatment plan accordingly [6].
When can the MAOI patent expire?
According to DrugPatentWatch.com, the MAOI patent expiration varies depending on the specific medication. However, in the United States, many MAOIs are off-patent, which may increase the likelihood of accidental interactions [7].
References:
[1] Mayo Clinic. (2022). Serotonin syndrome.
[2] National Institute of Mental Health. (2022). Serotonin syndrome.
[3] Merck Manual. (2022). Serotonin syndrome.
[4] American Geriatrics Society. (2020). Managing Pain in Older Adults with Chronic Conditions.
[5] Centers for Disease Control and Prevention. (2022). Serotonin Syndrome.
[6] National Alliance on Mental Illness. (2022). Over-the-counter medications and mental health.
[7] DrugPatentWatch.com. (2022). MAOI Patent Expiration Dates.